J&J | JNJ - Action





Action Changement Date
AbbVie USD 5.13B 78M 2026-06
Abbott USD 6.99B 501M 2026-03
Amgen USD 6.22B 34M 2026-06
AstraZeneca USD 6.93B 362M 2026-06
Baxter International USD 2.26B 57M 2026-06
Bayer EUR 11.97B 43M 2026-06
Becton, Dickinson and Co. USD 3.32B 41M 2026-06
Biogen USD 2.38B 435.3M 2026-06
Boston Scientific USD 3.24B 118M 2026-06
Bristol-Myers Squibb USD 2.74B 19M 2026-06
CONMED USD 360.18M 5.93M 2026-06
Cooper Companies USD 876.4M 30.4M 2025-12
Dexcom USD 726.4M 32.8M 2026-06
Edwards Lifesciences USD 1.13B 12.2M 2026-06
Eli Lilly USD 16.79B 2.26B 2026-06
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Globus Medical USD 810.9M 38.3M 2026-06
Insulet USD 484.8M 22.3M 2026-06
Integra LifeSciences USD 492M 3.03M 2026-06
Intuitive Surgical USD 2.03B 83.6M 2026-06
J&J USD 15.14B 561M 2026-06
Medtronic USD 5.95B 358M 2026-03
Merck USD 6.21B 272M 2026-06
Merit Medical Systems USD 374.11M 21.73M 2026-06
Novartis USD 6.22B 66M 2026-06
Pfizer USD 9.94B 722M 2026-06
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 24.12B 620M 2026-06
Stryker USD 5.52B 102M 2026-06
Tandem Diabetes Care USD 135.11M 8.71M 2026-06
Teva Pharmaceutical Industries USD 3.18B 3M 2026-03
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06
Zimmer Biomet Holdings USD 2.27B 23.5M 2026-06
Zoetis USD 2.57B 24M 2026-06